Regressin Uses, Dosage, Side Effects and more
Mycobacterial Cell Wall-DNA Complex (Regressin) is formulated from Mycobacterium phlei, a non-pathogenic strain of mycobacteria. Regressin has been shown to have immune stimulatory and apoptosis (programmed cell death) activity against cancer cells. The product is a sterile biological composition in a sub-micron suspension. It is produced at the Bioniche manufacturing facility in Pointe-Claire, Quebec.
| Attribute | Details |
|---|---|
| Trade Name | Regressin |
| Generic | MCC |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Bladder cancer
How Regressin works
Regressin has a therapeutic potential in high grade transitional cell carcinomas of the bladder, including refractory CIS. The combination of Regressin with hyaluronic acid (HA) enhances both the apoptosis-inducing activity of Regressin against prostate cancer cell lines, and the immune stimulatory activity of Regressin (stimulation of anticancer cytokine synthesis by human immune effector cells).
